SalmaJabbourMD(She/Her)

Radiation Oncology • New Brunswick, NJ

Gastrointestinal Cancer, Thoracic Cancer

Professor and Vice Chair of Clinical Research & Faculty Development; Clinical Chief

Join to view full profile

Dr. Jabbour is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Jabbour's full profile

Already have an account?

Office
195 Little Albany Street
Room 2013
New Brunswick, NJ 08903
Phone+1 732-253-3939

Fax+1 732-253-3952

Education & Training

Johns Hopkins UniversityResidency, Radiation Oncology, 2002 - 2006
University of MarylandInternship, Internal Medicine, 2001 - 2002
University of Maryland School of MedicineClass of 2001

Certifications & Licensure

NJ State Medical License 2006 - 2025
PA State Medical License 2004 - 2014
American Board of Radiology Radiation Oncology

Clinical Trials

Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC) Start of enrollment: 2019 Jul 26
Active, not recruiting
Phase 3

Publications & Presentations

PubMed

19 citations
Proton Reirradiation: Expert Recommendations for Reducing Toxicities and Offering New Chances of Cure in Patients With Challenging Recurrence Malignancies.
Charles B. Simone, John P. Plastaras, Salma K. Jabbour, Anna Lee, Nancy Y. Lee
Seminars in Radiation Oncology. 2020-07-01
115 citations
Pembrolizumab Plus Concurrent Chemoradiation Therapy in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer: The Phase 2 KEYNOTE-799 Non...
Salma K. Jabbour, Ki Hyeong Lee, Nikolaj Frost, Valeriy Breder, Dariusz M. Kowalski
JAMA Oncology. 2021-06-04
10 citations
Rationale and Design of the Phase III KEYLYNK-012 Study of Pembrolizumab and Concurrent Chemoradiotherapy Followed by Pembrolizumab With or Without Olaparib for Stage ...
Salma K Jabbour, Byoung Chul Cho, Emilio Bria, Terufumi Kato, Jaishree Bhosle
Clinical Lung Cancer. 2022-09-01

Lectures

Dosimetric Feasibility of 4DCT-Ventilation Imaging Guided Proton Therapy for Locally Advanced Non-Small-Cell Lung Cancer
2019 ASCO Annual Meeting - 6/1/2019